日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart

老药新招:替洛龙,一种广谱抗病毒药物,可作为治疗心脏疾病的抗纤维化药物

Duncan Horlock, David M Kaye, Catherine E Winbanks, Xiao-Ming Gao, Helen Kiriazis, Daniel G Donner, Paul Gregorevic, Julie R McMullen, Bianca C Bernardo

Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice

小分子偏向甲酰肽受体激动剂化合物 17b 可保护小鼠免受心肌缺血再灌注损伤

Cheng Xue Qin, Lauren T May, Renming Li, Nga Cao, Sarah Rosli, Minh Deo, Amy E Alexander, Duncan Horlock, Jane E Bourke, Yuan H Yang, Alastair G Stewart, David M Kaye, Xiao-Jun Du, Patrick M Sexton, Arthur Christopoulos, Xiao-Ming Gao, Rebecca H Ritchie

N-Acetylcysteine Attenuates the Development of Renal Fibrosis in Transgenic Mice with Dilated Cardiomyopathy

N-乙酰半胱氨酸减轻扩张型心肌病转基因小鼠肾脏纤维化的发展

Beverly Giam, Sanjaya Kuruppu, Po-Yin Chu, A Ian Smith, Francine Z Marques, April Fiedler, Duncan Horlock, Helen Kiriazis, Xiao-Jun Du, David M Kaye, Niwanthi W Rajapakse

N-acetylcysteine attenuates the development of cardiac fibrosis and remodeling in a mouse model of heart failure

N-乙酰半胱氨酸可减轻心力衰竭小鼠模型中心脏纤维化和重塑的发展

Beverly Giam, Po-Yin Chu, Sanjaya Kuruppu, A Ian Smith, Duncan Horlock, Helen Kiriazis, Xiao-Jun Du, David M Kaye, Niwanthi W Rajapakse

CXCR4 Antagonism Attenuates the Development of Diabetic Cardiac Fibrosis

CXCR4 拮抗作用可减缓糖尿病心脏纤维化的发展

Po-Yin Chu, Ken Walder, Duncan Horlock, David Williams, Erin Nelson, Melissa Byrne, Karin Jandeleit-Dahm, Paul Zimmet, David M Kaye